News

Jul 01, 2014

Relmada Therapeutics Files Shares Registration Statement
Read more here

Jun 16, 2014

Relmada Therapeutics Successfully Completes Offerings Totaling $28 Million in Connection with Going Public Transaction
Read more here

Jun 12, 2014

BioAdvance Portfolio Generated $450M in Fiscal 2014
Read more here

Jun 02, 2014

HealthQx Expands, Fueled by a New Round of Funding
Read more here

Jun 01, 2014

Sean Cunliffe Joins TREVENTIS Corporation as CEO
Read more here

May 09, 2014

Galleon’s Sleep Apnea Pill Nears Human Tests
Read more here

May 08, 2014

Novira Therapeutics Begins Phase 1a Clinical Study of NVR–1221 for the Treatment of Chronic Hepatitis B (HBV) Infection
Read more here

May 07, 2014

Galleon Pharmaceuticals Inc. Is Working On a More Simple Treatment for Sleep Apnea: A Pill
Read more here

Apr 14, 2014

No Snooze Button: Galleon Advances Drug Therapy for Sleep Apnea
Read more here

Apr 07, 2014

Venatorx Awarded NIH RO1 Grant
Read more here